Latest filing published 23 Apr 2018 for Surface Oncology, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -37.6%Entry US$23.54 · Close at T+365 US$14.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Novartis Institutes for BioMedical Research, Inc.: trading record in brief
Novartis Institutes for BioMedical Research, Inc. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Intellia Therapeutics, Inc., Surface Oncology, Inc. and Q32 Bio Inc. The record holds 10 filings, for trades running from 11 May 2016 to 23 April 2018.
Both buying and selling appear: 2 purchases worth €13.8M, against 1 sale worth €23.7M. The net balance comes to €9.9M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2018 to date brings 1 purchase and no sales.
On 23 April 2018 came the latest disclosure, a transaction in Surface Oncology, Inc. The most recent open-market purchase was published on 23 April 2018, 3,122 days ago. Most trades are made public on the day they happen. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Novartis Institutes for BioMedical Research, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,272,726 sharesCommon StockSEC:0001104659-18-025864:0
- 909,090 sharesCommon StockSEC:0001104659-18-025864:1
- 766,666 shares@ US$15.00100.0% of flowCommon StockSEC:0001104659-18-025864:2Canonical exit: 22 Jul 2018 (T+90)
- 1,979,226 shares0Common StockSEC:0000899243-18-009444:0
- 1,523,000 shares@ US$18.3084.4% of flowCommon StockSEC:0001104659-17-073312:0
- 79,245 shares0Common StockSEC:0001209191-17-018679:0
- 3,079,001 sharesCommon StockSEC:0001209191-16-119312:0
- 1,724,240 sharesCommon StockSEC:0001209191-16-119312:1
- 492,640 sharesCommon StockSEC:0001209191-16-119312:2
- 277,777 shares@ US$18.0015.6% of flowCommon StockSEC:0001209191-16-119312:3Canonical exit: 9 Aug 2016 (T+90)
10 of 10 declarations
